Swiss National Bank’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-73,300
| Closed | -$1.98M | – | 2492 |
|
|
2024
Q2 | $1.98M | Buy |
+73,300
| New | +$1.52M | ﹤0.01% | 1821 |
|
|
2023
Q4 | – | Sell |
-85,200
| Closed | -$1.28M | – | 2617 |
|
|
2023
Q3 | $1.28M | Buy |
85,200
+1,400
| +2% | +$29.1K | ﹤0.01% | 2103 |
|
|
2023
Q2 | $2.72M | Buy |
83,800
+1,500
| +2% | +$54.8K | ﹤0.01% | 1685 |
|
|
2023
Q1 | $3.22M | Sell |
82,300
-2,800
| -3% | -$137K | ﹤0.01% | 1543 |
|
|
2022
Q4 | $4.5M | Buy |
85,100
+1,800
| +2% | +$87.7K | ﹤0.01% | 1379 |
|
|
2022
Q3 | $3.75M | Buy |
83,300
+1,100
| +1% | +$47.3K | ﹤0.01% | 1451 |
|
|
2022
Q2 | $2.99M | Buy |
82,200
+3,800
| +5% | +$138K | ﹤0.01% | 1644 |
|
|
2022
Q1 | $3.24M | Buy |
78,400
+6,000
| +8% | +$211K | ﹤0.01% | 1737 |
|
|
2021
Q4 | $3.08M | Hold |
72,400
| – | – | ﹤0.01% | 1773 |
|
|
2021
Q3 | $3.98M | Buy |
72,400
+1,300
| +2% | +$68K | ﹤0.01% | 1627 |
|
|
2021
Q2 | $3.4M | Buy |
71,100
+9,000
| +14% | +$459K | ﹤0.01% | 1759 |
|
|
2021
Q1 | $3.15M | Buy |
62,100
+1,200
| +2% | +$66.7K | ﹤0.01% | 1738 |
|
|
2020
Q4 | $3.83M | Buy |
60,900
+300
| +0.5% | +$18.6K | ﹤0.01% | 1526 |
|
|
2020
Q3 | $4.07M | Buy |
60,600
+1,100
| +2% | +$60K | ﹤0.01% | 1303 |
|
|
2020
Q2 | $2.49M | Buy |
59,500
+23,600
| +66% | +$906K | ﹤0.01% | 1592 |
|
|
2020
Q1 | $1.13M | Buy |
35,900
+700
| +2% | +$28K | ﹤0.01% | 1756 |
|
|
2019
Q4 | $1.42M | Buy |
+35,200
| New | +$1.23M | ﹤0.01% | 1935 |
|
Other funds holding SILK
Swiss National Bank's SILK Position: Q3 2024 in Review
Swiss National Bank sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 73,300 shares — an estimated $1.98M sold.
Swiss National Bank first reported a position in SILK in Q4 2019 and held it in 17 quarters. The position peaked at $4.5M in Q4 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.
- Swiss National Bank reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
- Swiss National Bank sold 73,300 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $1.98M.
- Swiss National Bank first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 17 quarters.
- Swiss National Bank's Silk Road Medical, Inc. Common Stock position peaked at $4.5M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.
Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.